Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Lisa I. Backus"'
Autor:
George N. Ioannou, Jacqueline M. Ferguson, Ann M. O’Hare, Amy S. B. Bohnert, Lisa I. Backus, Edward J. Boyko, Thomas F. Osborne, Matthew L. Maciejewski, C. Barrett Bowling, Denise M. Hynes, Theodore J. Iwashyna, Melody Saysana, Pamela Green, Kristin Berry
Publikováno v:
PLoS Medicine, Vol 18, Iss 10 (2021)
Background We examined whether key sociodemographic and clinical risk factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and mortality changed over time in a population-based cohort study. Methods and findings In a coh
Externí odkaz:
https://doaj.org/article/ff071a088e724eb9b8b417c49e69afdd
Autor:
Pamela Green, C. Barrett Bowling, Lisa I. Backus, Thomas F. Osborne, Theodore J. Iwashyna, Matthew L. Maciejewski, Denise M. Hynes, George N. Ioannou, Melody Saysana, Jacqueline M Ferguson, Amy S.B. Bohnert, Ann M. O’Hare, Edward J. Boyko, Kristin Berry
Publikováno v:
PLoS Medicine, Vol 18, Iss 10 (2021)
PLoS Medicine, Vol 18, Iss 10, p e1003807 (2021)
PLoS Medicine
PLoS Medicine, Vol 18, Iss 10, p e1003807 (2021)
PLoS Medicine
Background We examined whether key sociodemographic and clinical risk factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and mortality changed over time in a population-based cohort study. Methods and findings In a coh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e556d9d949f99ea048bb2c9e15352b3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530298/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530298/?tool=EBI
Autor:
Vincent S. Fan, Kristin Berry, Lisa I. Backus, George N. Ioannou, Pamela Green, Thomas F. Osborne, McKenna C Eastment, Ann M. O’Hare, Nikolas G Ioannou, Jason A. Dominitz, Emily Locke
Publikováno v:
JAMA Network Open
Key Points Question How can the risk of SARS-CoV-2–related death be estimated in the general population to be used for vaccination prioritization? Findings In this prognostic study of more than 7.6 million individuals enrolled in the Veterans Affai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff1bc64de00d4c10e295c9e8280b7c4
https://pubmed.ncbi.nlm.nih.gov/33822074
https://pubmed.ncbi.nlm.nih.gov/33822074
Autor:
Maggie Chartier, Timothy R. Morgan, Rachel Gonzalez, Angela Park, Pamela S. Belperio, Lisa I. Backus, David B. Ross
Publikováno v:
Infectious Disease Clinics of North America. 32:281-292
The Department of Veterans Affairs (VA) has made significant progress in treating hepatitis C virus, experiencing more than a 75% reduction in veterans remaining to be treated since the availability of oral direct-acting antivirals. Hepatitis C Innov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50d59c18025ed4b29e384765757310a9
https://doi.org/10.1016/j.idc.2018.02.011
https://doi.org/10.1016/j.idc.2018.02.011
Publikováno v:
Hepatology. 66:27-36
Reactivation of hepatitis B virus (HBV) has been reported in hepatitis C virus–infected individuals receiving direct-acting antiviral (DAA) therapy. The overall risk among patients with current or prior HBV infection in the context of DAA treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::849c87250faf832ed78d4e85f86c7da7
https://doi.org/10.1002/hep.29135
https://doi.org/10.1002/hep.29135
Autor:
Troy A. Shahoumian, Larry A. Mole, Lisa I. Backus, Debika Bhattacharya, Timothy P. Loomis, Pamela S. Belperio, Matthew Bidwell Goetz
Publikováno v:
Clinical Infectious Diseases. 64:1711-1720
Author(s): Bhattacharya, Debika; Belperio, Pamela S; Shahoumian, Troy A; Loomis, Timothy P; Goetz, Matthew B; Mole, Larry A; Backus, Lisa I | Abstract: Background.Large cohorts are needed to assess human immunodeficiency virus (HIV)/hepatitis C virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17621b8c6d5514b58f10d077b362b6b5
https://doi.org/10.1093/cid/cix111
https://doi.org/10.1093/cid/cix111
Autor:
Lisa I. Backus, Pamela S. Belperio, Mark Holodniy, Troy A. Shahoumian, Mark A. Winters, Thomas R. O'Brien, Ludmila Prokunina-Olsson
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 92:34-36
In direct acting antiviral (DAA)-treated HCV genotype 1, the sustained virologic response rate with the ∆G/∆G genotype of IFNL4 rs368234815 (86.8%) was significantly lower than with ∆G/TT (95.9%, P = 0.03) or TT/TT (98.6%, P = 0.01). The SVR od
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89ddc384e86fa8fb14e854a7b531709
https://doi.org/10.1016/j.diagmicrobio.2018.04.004
https://doi.org/10.1016/j.diagmicrobio.2018.04.004
Publikováno v:
Journal of viral hepatitis. 26(8)
Sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) provides a needed hepatitis C virus (HCV) antiviral option for direct-acting antiviral (DAA)-experienced patients. We evaluated the effectiveness of SOF/VEL/VOX for 12 weeks in DAA-experienced patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e900bf6789bf32d93997c34db82cbf3
https://pubmed.ncbi.nlm.nih.gov/31012179
https://pubmed.ncbi.nlm.nih.gov/31012179
Publikováno v:
Alimentary Pharmacology & Therapeutics. 44:400-410
Real-world data are needed to inform hepatitis C virus (HCV) treatment decisions.To assess the comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin (LDV/SOF ± RBV) vs. ombitasvir/paritaprevir/ritonavir + dasabuvir (OPrD) ± RBV in genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d602fa0fa130c25d6f75871f1af89bd
https://doi.org/10.1111/apt.13696
https://doi.org/10.1111/apt.13696
Publikováno v:
Hepatology. 64:405-414
Real-world effectiveness data are needed to inform hepatitis C virus (HCV) treatment decisions. The uptake of ledipasvir/sofosbuvir (LDV/SOF) regimens across health care settings has been rapid, but variations often occur in clinical practice. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3511a356c524663dc8722fc9eae1fe
https://doi.org/10.1002/hep.28625
https://doi.org/10.1002/hep.28625